Why did Tesla's stock soar after robotaxi launch?
How will US-Iran conflict impact oil prices?
What caused Kroger to announce store closures?
Why are Fed officials signaling potential rate cuts?
How is the Iran strike affecting global markets?
What’s behind Compass suing Zillow over listings?
Why is Fiserv entering the stablecoin market?
CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug
investors.com/news/technology/cormedix-stock-defencath-large-dialysis-organization
CorMedix shares bounded to a four-year high Monday after the biotech company inked an expanded deal for its leading drug, DefenCath.
The post CorMedix Spikes To Four-Year High On A Surprise Deal For Its Leading Drug appeared first on Investor's Business Daily.
This story appeared on investors.com, 2025-06-23 18:51:07.